Nivolumab in pretreated non-small cell lung cancer: continuing the immunolution

od Salati, Massimiliano, Baldessari, Cinzia, Cerbelli, Bruna, Botticelli, Andrea
Izdano u Transl Lung Cancer Res (2018)

CAR-T with License to Kill Solid Tumors in Search of a Winning Strategy

od Sacchetti, Benedetto, Botticelli, Andrea, Pierelli, Luca, Nuti, Marianna, Alimandi, Maurizio
Izdano u Int J Mol Sci (2019)

Agnostic evaluation of ipilimumab and nivolumab association: a metanalysis

od Marchetti, Paolo, Botticelli, Andrea, Ascierto, Antonio Paolo, Curigliano, Giuseppe, Giannarelli, Diana
Izdano u J Transl Med (2020)

Risk of SARS-CoV-2 infection and disease in metastatic triple-negative breast cancer patients treated with immune checkpoint inhibitors

od Vici, Patrizia, Pizzuti, Laura, Krasniqi, Eriseld, Botticelli, Andrea, Ciliberto, Gennaro, Barba, Maddalena
Izdano u Immunotherapy (2020)

Crizotinib plus radiotherapy in brain oligoprogressive NSCLC ROS1 rearranged and PD-L1 strong

od Occhipinti, Mario, Falcone, Rosa, Onesti, Concetta Elisa, Botticelli, Andrea, Mazzuca, Federica, Marchetti, Paolo, Lauro, Salvatore
Izdano u J Thorac Dis (2017)

Biliary tract cancer: current challenges and future prospects

od Ghidini, Michele, Pizzo, Claudio, Botticelli, Andrea, Hahne, Jens Claus, Passalacqua, Rodolfo, Tomasello, Gianluca, Petrelli, Fausto
Izdano u Cancer Manag Res (2018)

The role of stereotactic body radiation therapy in oligometastatic colorectal cancer: Clinical case report of a long-responder patient treated with regorafenib beyond progression

od Roberto, Michela, Falcone, Rosa, Mazzuca, Federica, Archibugi, Livia, Castaldi, Nadia, Botticelli, Andrea, Osti, Mattia Falchetto, Marchetti, Paolo
Izdano u Medicine (Baltimore) (2017)

Standard of Care and Promising New Agents for the Treatment of Mesenchymal Triple-Negative Breast Cancer

od Mezi, Silvia, Botticelli, Andrea, Pomati, Giulia, Cerbelli, Bruna, Scagnoli, Simone, Amirhassankhani, Sasan, d’Amati, Giulia, Marchetti, Paolo
Izdano u Cancers (Basel) (2021)

Electrochemotherapy as Promising Treatment Option in Rare Recurrent Cutaneous Neoplasm of the Scalp: Case Report of an Elderly Patient

od Crimini, Edoardo, Roberto, Michela, Degli Effetti, Valter, Marchetti, Paolo, Botticelli, Andrea, Schipilliti, Francesca Matilde, Arrivi, Giulia, Mazzuca, Federica
Izdano u Case Rep Oncol Med (2019)

Cross-talk between microbiota and immune fitness to steer and control response to anti PD-1/PDL-1 treatment

od Botticelli, Andrea, Zizzari, Ilaria, Mazzuca, Federica, Ascierto, Paolo Antonio, Putignani, Lorenza, Marchetti, Luca, Napoletano, Chiara, Nuti, Marianna, Marchetti, Paolo
Izdano u Oncotarget (2016)

Effect of MTHFR Polymorphisms on Gastrointestinal Cancer Risk in Italy

od Mazzuca, Federica, Borro, Marina, Botticelli, Andrea, Aimati, Laura, Gentile, Giovanna, Capalbo, Carlo, Maddalena, Chiara, Mazzotti, Eva, Simmaco, Maurizio, Marchetti, Paolo
Izdano u World J Oncol (2015)

Lean body mass wasting and toxicity in early breast cancer patients receiving anthracyclines

od Mazzuca, Federica, Onesti, Concetta Elisa, Roberto, Michela, Di Girolamo, Marco, Botticelli, Andrea, Begini, Paola, Strigari, Lidia, Marchetti, Paolo, Muscaritoli, Maurizio
Izdano u Oncotarget (2018)

Can IDO activity predict primary resistance to anti-PD-1 treatment in NSCLC?

od Botticelli, Andrea, Cerbelli, Bruna, Lionetto, Luana, Zizzari, Ilaria, Salati, Massimiliano, Pisano, Annalinda, Federica, Mazzuca, Simmaco, Maurizio, Nuti, Marianna, Marchetti, Paolo
Izdano u J Transl Med (2018)

Strategies for Increasing the Effectiveness of Aromatase Inhibitors in Locally Advanced Breast Cancer: An Evidence-Based Review on Current Options

od Grizzi, Giulia, Ghidini, Michele, Botticelli, Andrea, Tomasello, Gianluca, Ghidini, Antonio, Grossi, Francesco, Fusco, Nicola, Cabiddu, Mary, Savio, Tommaso, Petrelli, Fausto
Izdano u Cancer Manag Res (2020)

Immunotherapy in the Treatment of Metastatic Melanoma: Current Knowledge and Future Directions

od Ralli, Massimo, Botticelli, Andrea, Visconti, Irene Claudia, Angeletti, Diletta, Fiore, Marco, Marchetti, Paolo, Lambiase, Alessandro, de Vincentiis, Marco, Greco, Antonio
Izdano u J Immunol Res (2020)

An Italian cost-effectiveness analysis of paclitaxel albumin (nab-paclitaxel) versus conventional paclitaxel for metastatic breast cancer patients: the COSTANza study

od Lazzaro, Carlo, Bordonaro, Roberto, Cognetti, Francesco, Fabi, Alessandra, De Placido, Sabino, Arpino, Grazia, Marchetti, Paolo, Botticelli, Andrea, Pronzato, Paolo, Martelli, Elisa
Izdano 2013

CYP19A1 Genetic Polymorphisms rs4646 and Osteoporosis in Patients Treated with Aromatase Inhibitor-Based Adjuvant Therapy

od Mazzuca, Federica, Botticelli, Andrea, Mazzotti, Eva, La Torre, Marco, Borro, Marina, Marchetti, Luca, Maddalena, Chiara, Gentile, Giovanna, Simmaco, Maurizio, Marchetti, Paolo
Izdano u Eurasian J Med (2016)

Pre-treatment evaluation of 5-fluorouracil degradation rate: association of poor and ultra-rapid metabolism with severe toxicity in a colorectal cancer patients cohort

od Mazzuca, Federica, Borro, Marina, Botticelli, Andrea, Mazzotti, Eva, Marchetti, Luca, Gentile, Giovanna, La Torre, Marco, Lionetto, Luana, Simmaco, Maurizio, Marchetti, Paolo
Izdano u Oncotarget (2016)

How to Best Exploit Immunotherapeutics in Advanced Gastric Cancer: Between Biomarkers and Novel Cell-Based Approaches

od Ghidini, Michele, Petrillo, Angelica, Botticelli, Andrea, Trapani, Dario, Parisi, Alessandro, La Salvia, Anna, Sajjadi, Elham, Piciotti, Roberto, Fusco, Nicola, Khakoo, Shelize
Izdano u J Clin Med (2021)

Clinical Impact of Highly Purified, Whey Proteins in Patients Affected With Colorectal Cancer Undergoing Chemotherapy: Preliminary Results of a Placebo-Controlled Study

od Mazzuca, Federica, Roberto, Michela, Arrivi, Giulia, Sarfati, Elena, Schipilliti, Francesca Matilde, Crimini, Edoardo, Botticelli, Andrea, Di Girolamo, Marco, Muscaritoli, Maurizio, Marchetti, Paolo
Izdano u Integr Cancer Ther (2019)